Vanessa Rivera-Amill to Dengue Vaccines
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Dengue Vaccines.
Connection Strength
0.625
-
Medina FA, Vila F, Adams LE, Cardona J, Carrion J, Lamirande E, Acosta LN, De Le?n-Rodr?guez CM, Beltran M, Grau D, Rivera-Amill V, Balmaseda A, Harris E, Madewell ZJ, Waterman SH, Paz-Bailey G, Whitehead S, Mu?oz-Jord?n JL. Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination. J Clin Microbiol. 2024 Oct 16; 62(10):e0059324.
Score: 0.221
-
Adams LE, Hitchings MDT, Medina FA, Rodriguez DM, S?nchez-Gonz?lez L, Moore H, Whitehead SS, Mu?oz-Jord?n JL, Rivera-Amill V, Paz-Bailey G. Previous Dengue Infection among Children in Puerto Rico and Implications for Dengue Vaccine Implementation. Am J Trop Med Hyg. 2023 08 02; 109(2):413-419.
Score: 0.203
-
Rodriguez DM, Major CG, S?nchez-Gonz?lez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023 06 01; 41(24):3627-3635.
Score: 0.202